When: June 16, 2021, 12 p.m. ET
Case Study: Modeling disease progression in polycystic kidney disease to inform trial design
Presenters: Rhoda Muse, PhD, Scientist 1, Quantitative Medicine; Klaus Romero, MD, MS, FCP, Chief Science Officer and Executive Director of Clinical Pharmacology; Jackson Burton, PhD, Executive Director, Quantitative Medicine
RDCA-DAP Team: Jeff Barrett, PhD, FCP., Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP
This event is part of a new webinar series, for additional webinars visit c-path.org/rdca-dap/resources
